Entrar/Registro  
HOME SPANISH
 
Revista Médica del Instituto Mexicano del Seguro Social
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2016, Issue S3


Guerra-Castillo FX, Ramos-Cervantes MT, Rosel-Pech C, Jiménez-Hernández E, Bekker-Méndez VC
PCR detection of relevant translocations in pediatric acute lymphoblastic leukemia
Rev Med Inst Mex Seguro Soc 2016; 54 (S3)

Language: Español
References: 23
Page: 302-308
PDF: 326.64 Kb.


Full text




ABSTRACT

Background: In Mexico, leukemia represents the most common type of cancer in the population under 15 years old with a high incidence rate when compared with developed countries. The etiology of leukemia may be unknown, however different factors are involve such as chromosomal translocations. The aim of this work is to detect the molecular alterations: TEL-AML1, MLL-AF4, BCR-ABL minor and E2A-PBX1 in pediatric patients with acute lymphoblastic leukemia.
Methods: 91 bone marrow samples were collected from pediatric patients with acute lymphoblastic leukemia from january 2012 to march 2013 at the Pediatric Hematology Service, Hospital General “Gaudencio González Garza”. Translocations detected (TEL-AML1, MLL-AF4, BCRABL minor and E2A-PBX1) using real time PCR, SYBR Green (Qiagen, Alameda, CA).
Results: 91 samples were processed, the detected frequencies for each translocation were: TEL-AML1 (7.21%), E2A-PBX1 (5.15%). The MLLAF4 and the BCR-ABL minor translocations were not detected in this study.
Conclusions: The frequencies shown in this study are consistent with the data shown in the literature, where TEL-AML1 is the most common translocation found in pediatric patients. It is of relevance to mention that E2A-PBX1 is found in a high frequency in developing countries when compared with developed countries.


Key words: Leukemia, Child, Neoplasms, Bone marrow.


REFERENCIAS

  1. Dirección de Prevención y Tratamiento del Cáncer en la Infancia y la Adolescencia-CeNSIA. Base de datos de cáncer 2007-2008. Información brindada por los Hematólogos y Oncólogos pedíatras de las UMA pertenecientes a la Secretaría de Salud de 31 entidades federativas.

  2. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez- Ríos R, Martínez-Avalos A, Medina-Sanson A, Espinosa- Hernández L et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11:355.

  3. Hoffman R, Benz E, Silberstein L, Heslop H, Weitz J, Anastasi J. Hematology. London: Elsevier Health Sciences; 2013.

  4. Swerdlow SH, Campo E, Harris NL, Jaffe ES, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues. Annals of Oncology. 2002; 13(3):490-491.

  5. Cotran R, Kumar V, Collins T, Robbins S, et al. Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book, 8º edición, Philadelphia: Elsevier; 2010.

  6. Pui C, Mullighan C, Evans W, Relling M. Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there?. Blood. 2012;120(6):1165-1174.

  7. Pui C. Treatment of acute leukemias: Diagnosis, classification and prognosis; Classification of acute leukemias. Totowa, N.J.: Humana Press; 2003.

  8. Pui C, Campana D, Evans W. Childhood acute lymphoblastic leukaemia -current status and future perspectives. The Lancet Oncology. 2001;2(10):597-607.

  9. Wood A, Pui C, Evans W. Acute Lymphoblastic Leukemia. New Engl J Medicine. 1998;339(9):605-15.

  10. Van Dongen J, Macintyre E, Gabert J, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia. 1999;13(12):1901-1928.

  11. Siraj A, Ozbek U, Sazawal S, Sirma S, Timson G, Al- Nasser A, et al. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia. Clin Cancer Res Official J Am Assoc Cancer Res. 2002; 8(12):3832-40.

  12. Dorak, M. Real Time PCR. Primera Edición. Reino Unido: Taylor & Francis Group; 2006.

  13. Ferrando AA, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Seminars in hematology. 2000;37:381-395.

  14. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27(11): 2165-2176.

  15. Bekker-Méndez VC, Miranda-Peralta E, Núñez- Enríquez JC, Olarte-Carrillo I, Guerra-Castillo FX, Pompa-Mera EN et al. Prevalence of Gene Rearrangements in Mexican Children with Acute Lymphoblastic Leukemia: A Population Study-Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia. BioMed Research International. 2014;2014:210560.

  16. Pérez-Vera P, Salas C, Montero-Ruiz O, Frías S, Dehesa G, Jarquín B et al. Analysis of gene rearrangements using a fluorescence in situ hybridization method in Mexican patients with acute lymphoblastic leukemia: experience at a single institution. Cancer Genetics and Cytogenetics. 2008;184(2):94-98.

  17. Siraj AK, Kamat S, Gutierrez MI, et al. Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the west. Leukemia. 2003;17(6):1192-1193.

  18. Mesquita DR, Córdoba JC, Magalhães IQ, Córdoba MS, Oliveira JRC, Goncalves A et al. Molecular and chromosomal mutations among children with Blineage lymphoblastic leukemia in Brazil’s Federal District. Genetics and Molecular Research. 2009;8 (1):345-353.

  19. Loh ML, Rubnitz JE. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol. 2002;9(4):345-352.

  20. Borkhardt A, Harbott J, Lampert F. Biology and clinical significance of the TEL/AML1 rearrangement. Curr Opin Pediatr, 1999;11(1):33-38.

  21. Jiménez-Morales S, Miranda-Peralta E, Saldaña- Alvarez Y, et al. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: Prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients. Leukemia Research. 2008;32(10):1518-1522.

  22. Daniel-Cravioto A, Gonzalez-Bonilla CR, Mejia- Arangure JM, Perez-Saldivar ML, Fajardo-Gutierrez A, Jimenez-Hernandez E et al. Genetic rearrangement MLL/AF4 is most frequent in children with acute lymphoblastic leukemias in Mexico City. Leukemia and Lymphoma. 2009;50(8):1352-1360.

  23. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27(11):2165-76.






>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2016, Issue S3
 

· Journal Index 
· Links 






       
Copyright 2019